By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Numerous conferences provide expensive opportunities to present to potential investors and in-licensors. The Innovator’s Pitch Challenge (IPC) at the Redefining Early Stage Investments (RESI) event is different: We have a panel of well-aligned investors who not only listen to but also provide interactive feedback on your pitch. Not to mention an additional audience of investors/in-licensors. You are more likely to secure an investment or deal after a presentation at RESI than at other conferences.
Curated Investor Audience
Unlike some conferences that allow companies to purchase pricey “Presenting Company” or “Showcase” slots, the IPC sessions are carefully curated based on the specific technology areas of each participating company. This ensures that companies are pitching directly to a panel of investor judges who are actively investing in and deeply understand the relevant market dynamics. RESI caters to the early stage, featuring prices 50% lower than other events.
Invaluable Expert Feedback
After each pitch, the investor judges provide detailed feedback to the presenting company. This insider perspective on how to improve the pitch, positioning, and overall investment narrative is an invaluable resource. We provide a written summary of this feedback to you.
Technology Display in the Poster Exhibition
This poster exhibition allows IPC companies to have a physical presence at the event, interact directly with attendees, and further promote their technology and capabilities. The poster format gives these early-stage innovators an additional platform to engage with investors, partners, and industry peers who attend the conference. This dual opportunity – to pitch to a targeted investor panel as well as present at the poster exhibition – makes the IPC at RESI a unique experience for life sciences startups seeking investment and strategic connections. The poster exhibition component provides IPC companies with enhanced visibility and the ability to directly showcase their technology to the full conference audience.
Networking and Connections
In addition to the pitching sessions, the IPC facilitates networking opportunities for participating companies to connect with potential investors, partners, and peers in a focused environment. Many companies have leveraged these connections to secure tangible leads and partnerships.
Tailored for Early-Stage Life Sciences
The Innovator’s Pitch Challenge at RESI is specifically designed to support early-stage life sciences companies in their pursuit of investment capital and strategic partnerships. For entrepreneurs in this sector seeking smart money and growth opportunities, the IPC provides a unique and valuable platform to showcase their innovations to a highly relevant and engaged audience of investors and industry stakeholders.
Hear from previous IPC Winners about their IPC experience:
17 Startups, 7 Unicorns, and $7M of a $37M Round Raised at RESI – Read More
An interview with Thomas Farb-Horch, CEO, Thrive Bioscience
Liquet Medical has First-Time RESI Success! – Read More
Interview with John Schindler, CEO at Liquet Medical and John Newby, CEO at Virginiabio
IPC Winner, Sanguina, Finds Connection at RESI South – Read More
Interview with Erika Tyburski, CEO at Sanguina and Maria Thacker-Goethe, President & CEO at Georgia Bio
Gliachem’s Innovator’s Pitch Challenge Success at RESI – Read More
Interview with Vanessa Williamson, Entrepreneur-in-Residence/CEO at Gliachem
Rx Bandz Finds Great Success at RESI – Read More
Interview with Jessica Walsh, Founder and CEO, Rx Bandz
Light Line Medical wins the Innovator’s Pitch Challenge and Looks Toward Their Series B Raise – Read More
Interview with Kari Haab, Head of Operations at Light Line Medical and Kevin Shifrin, Vice President of Marketing at Light Line Medical
RESI Europe registration opens at early bird rates. Register now to save $300 by Friday, May 17th.
Next Phase Newsletter 